Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/26/16 → 07/25/19 |
Funding
- Novo Nordisk Incorporated: $202,300.00
NN1218-4101 Efficacy and Safety of Fasteracting Insulin Aspart compared to NovoRapid? both in Combination with Insulin Degludec in Children and Adolescents with Type 1 Diabetes - onset?7 Trial Phase 3b
- Bethin, Kathleen (PI)
Project: Research